Beijing Amsino Medical Instruments Co., Ltd., referred to as Amsino, was established in 1999 with a registered capital of RMB 24,625,600 and is situated within the Beijing Miyun Industrial Development Zone. Amsino proudly stands as a pioneer among high-tech enterprises, specializing in the research, development, production, sales, and service of cutting-edge medical devices tailored for cardiac intervention.
On January 15, 2016, Amsino achieved a significant milestone by successfully listing on the New Third Board. Over the years, our commitment has been unwavering, as we continuously introduce the latest products and technologies in the field of foreign cardiac intervention to China. We actively foster a platform for communication between domestic and foreign physicians, which significantly contributes to elevating the interventional treatment capabilities of our nation's cardiovascular physicians.
Our remarkable achievements span diverse areas, including cardiac pacemakers, electrophysiology, coronary intervention, artificial heart valves, and more. These accomplishments have positioned Amsino as a highly influential professional enterprise within the domestic industry.
Beijing Amsino Medical Co., Ltd. is the first-generation high-tech enterprise engaging in R&D, production,
sales and service of medical devices in the field of cardiac intervention.
Within the heart and blood vessel patient community, we leverage the HeartGuard Big Data Platform to deliver holistic solutions to residents, spanning medical device products and health financial services. Our development approach combines industry and finance, with a primary focus on establishing core businesses within the heart and blood vessel patient ecosystem. Additionally, we continuously seek, nurture, and cultivate new strategic core businesses within the broader healthcare industry to create a prominent healthcare holding company specializing in heart and vascular disease services. This enables us to realize a comprehensive spectrum of medical services, extending beyond medical products.
Originality is deeply embedded in Amsino's DNA. We firmly believe that this represents the future of Intelligent Manufacturing in China. Our unwavering commitment to this vision is driven by the belief that our perseverance will ultimately benefit society and people worldwide.
